QA: Immune Design CORP in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001437786_2018_Immune_Design_CORP.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001437786, Immune Design CORP

  xvar xval
0 AssetsCurrent 153,143,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 491,000
3 remainder_Assets 200,000
4 LiabilitiesCurrent 14,520,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,102,644
9 ResearchAndDevelopmentExpense 42,518,050
10 remainder_Expenses -101,538
11 remainder_Revenues 6,270,104
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 1,100,929
  yvar yval
0 Assets 153,834,000
1 Liabilities 14,520,000
2 Expenses 58,519,156
3 Revenues 6,270,104
4 StockholdersEquity 139,314,000
5 NetIncome -52,249,052
6 ComprehensiveNetIncome -51,698,588
7 BaseVar 117,122,094
8 EconomicCapitalRatiobeforeLimitedLiability 2.99
9 EconomicCapitalRatio 3.68

Edgar->Model Mapping

Feature Distribution

Change over Time